Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

Oncology (Williston Park, N.Y.)

Volumn 14, Issue 11, 2000, Pages 1589-1590,-1593

  Wright, J ^a   Hillsamer, V L ^a   Gore Langton, R E ^a   Cheson, B D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD DISEASE; HUMAN; NEOPLASM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASMS; PROTEASE INHIBITORS; PYRAZINES;

EID: 0034321816     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)